about
Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failureDevelopment of respiratory control instability in heart failure: a novel approach to dissect the pathophysiological mechanismsEvidence-based recommendations for PISA measurements in mitral regurgitation: systematic review, clinical and in-vitro study.Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation indexPatient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility.Effect of study design on the reported effect of cardiac resynchronization therapy (CRT) on quantitative physiological measures: stratified meta-analysis in narrow-QRS heart failure and implications for planning future studiesGuidance for accurate and consistent tissue Doppler velocity measurement: comparison of echocardiographic methods using a simple vendor-independent method for local validation.The arterial reservoir pressure increases with aging and is the major determinant of the aortic augmentation index.Choosing between velocity-time-integral ratio and peak velocity ratio for calculation of the dimensionless index (or aortic valve area) in serial follow-up of aortic stenosis.Novel cardiac pacemaker-based human model of periodic breathing to develop real-time, pre-emptive technology for carbon dioxide stabilisation.Attenuation of wave reflection by wave entrapment creates a "horizon effect" in the human aorta.What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice.Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interventricular delayAbnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patientsThe acute effects of changes to AV delay on BP and stroke volume: potential implications for design of pacemaker optimization protocols.Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constantInduction of oscillatory ventilation pattern using dynamic modulation of heart rate through a pacemakerDetection of metallic cobalt and chromium liver deposition following failed hip replacement using T2* and R2 magnetic resonanceA novel fully automated method for mitral regurgitant orifice area quantification.Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure.Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post-Reperfused ST-Elevation Myocardial Infarction.Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment-Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling.Dynamic CO2 therapy in periodic breathing: a modeling study to determine optimal timing and dosage regimes.Novel use of cardiac pacemakers in heart failure to dynamically manipulate the respiratory system through algorithmic changes in cardiac output.Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance.Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance.Applicability of the iterative technique for cardiac resynchronization therapy optimization: full-disclosure, 50-sequential-patient dataset of transmitral Doppler traces, with implications for future research design and guidelines.T1 mapping: non-invasive evaluation of myocardial tissue composition by cardiovascular magnetic resonance.Myocardial T1 mapping.Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping.Diagnostic performance of T1 and T2 mapping to detect intramyocardial hemorrhage in reperfused ST-segment elevation myocardial infarction (STEMI) patientsInsight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping.Cardiac MRI evaluation of myocardial disease.Provision of magnetic resonance imaging for patients with 'MR-conditional' cardiac implantable electronic devices: an unmet clinical need.Automatic Measurement of the Myocardial Interstitium: Synthetic Extracellular Volume Quantification Without Hematocrit Sampling.Evaluation of splenic switch off in a tertiary imaging centre: validation and assessment of utility.Splenic Switch-off: A Tool to Assess Stress Adequacy in Adenosine Perfusion Cardiac MR Imaging.Safe use of MRI in people with cardiac implantable electronic devices.
P50
Q22306537-6C9B1711-7A02-4A3B-A7EF-1D151C02D70CQ24669768-7F4169E7-D3DE-4056-9903-A4485DC73C90Q26852227-EA0D291E-9D49-4C4F-BCD8-E3C9386295CFQ26861653-9B43E47E-2ACE-45BD-BE7B-A530B8CF9E11Q27339134-B28D9505-F97A-4F73-8502-2E90B6D0A779Q28085449-A729D848-3166-430C-B3E4-08E92B562481Q31155854-39662625-DD69-49E2-9F4E-F57B41531CE6Q33655962-5E34E77D-03E0-459E-83CA-EAC0C73EDA17Q34274042-DA20499A-CAB2-448D-9D30-8EDEDC8A7EE4Q34304383-D9DDA003-69FE-4F53-9C45-16EF9B3247A4Q34339254-9E16F22D-3352-43F6-A8CB-5CE4D4A096E2Q34409791-F95B625E-C9DE-4A87-BBB0-DDF538062E70Q35772700-5CC939F8-4390-4496-8955-ED85F50B267FQ35899352-8F0D2C31-E0E4-4A7C-A7AB-7DDBC60682F3Q35945907-11507A53-6370-4B53-A9F5-A0B61A8F5D3DQ36043353-5BDDA40B-F3AD-4BE1-9D21-3D0CD29A2035Q36165179-CBD3738B-F5BB-4EAB-A4C5-C460089CF260Q36428817-525E624A-4780-4D90-A896-883FD97E69CCQ36808175-80BDFEB7-D08D-4808-B372-516470101495Q36879780-97B8ADBA-AEE8-4626-BF17-DA3FB14B1CC3Q36910356-1CDEC154-A0F8-4E92-8F85-3860FC9FF1AEQ37226260-F6A79FF2-60C6-40EE-A6EB-426925126841Q37240733-EF31BCD7-1E90-4DC0-BC00-EDC7E83CA2E7Q37346530-651CEE47-718E-497C-AAEA-8759B5C6F132Q37372413-1F931824-5B46-4E4E-AC0E-AC07403A2D3AQ37380890-B116AB90-F3A8-4BF1-9D12-B7C523FC62F2Q37521985-B426836C-5F59-486B-85A8-E5F63ACC205EQ37695032-18FEC536-2B6D-4970-BF0C-9386A4AFE004Q38143684-CD7632A3-7F9A-4DB2-AC98-FA4DFFA5CB67Q38270769-A5D02C66-96F2-4BDC-8A2D-06AA49C77820Q38369121-49745812-3D9E-4571-A456-7DE4A5BF461AQ38400610-92AA4148-9014-4648-BEF9-FA2111743547Q38405758-DB71E9C4-A416-409E-AF69-E3FA11225298Q38410986-3170CEFF-1DB0-4CBC-9DD0-1CDCBE8467B8Q38413105-C472EA4F-7F9C-461E-BBA8-8FCF574A8DCDQ38413818-3F5C11FA-90ED-4958-A75F-BAC2CCA38125Q38418247-DB5F3CF6-FDAF-45D0-BF5F-180C64E1B582Q38418837-2E7D6049-1220-4EF1-85A2-02BFBB289A25Q38426529-8FB44B49-D0C7-47E5-AD7A-5D4E124A7AFBQ38595564-0450CA24-D31F-4586-B1C6-4C006A4C4E1E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Charlotte Manisty
@ast
Charlotte Manisty
@en
Charlotte Manisty
@es
Charlotte Manisty
@nl
Charlotte Manisty
@sl
type
label
Charlotte Manisty
@ast
Charlotte Manisty
@en
Charlotte Manisty
@es
Charlotte Manisty
@nl
Charlotte Manisty
@sl
prefLabel
Charlotte Manisty
@ast
Charlotte Manisty
@en
Charlotte Manisty
@es
Charlotte Manisty
@nl
Charlotte Manisty
@sl
P106
P1153
6504025861
P21
P31
P496
0000-0003-0245-7090